Track Nobilis Health Corp. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Nobilis Health Corp. NRTSF · Stock Open Nobilis Health Corp. in new tab

0.00000100 USD
P/E
0.00
P/B
0.00
Loading chart...
Key Metrics
P/E0.00
Book Value1.91
Price to Book0.00

DCF valuation

Model fair value for Nobilis Health Corp. (NRTSF)
Result
Sign in to run the valuation for NRTSF.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Nobilis Health Corp. Logo Nobilis Health Corp. Analysis (NRTSF)

United States Health Care Official Website Stock

Is Nobilis Health Corp. a good investment? Nobilis Health Corp. (NRTSF) is currently trading at 0.00000100 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.00. This relatively low multiple may signal that Nobilis Health Corp. is undervalued compared to historical market norms.

Investor FAQ

Does Nobilis Health Corp. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Nobilis Health Corp.?

Nobilis Health Corp. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Nobilis Health Corp. engages in the operation and development of outpatient surgery centers. The firm owns and manages ambulatory and acute care facilities to deliver innovative surgical services. It operates through Medical Services and Marketing Services segment. The Medical Services segment provides the operation of hospitals, outpatient facilities, and other various related health care services. The Marketing Services segment provides marketing services, patient education services, and patient care coordination management services. The company was founded on March 16, 2007 and is headquartered in Houston, TX.

Exchange Ticker
PNK (United States) NRTSF
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion